Cargando…

PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway

Background: Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1), a co-activator of estrogen receptors alpha, was confirmed to be directly associated with the oncogenic process of multiple cancers, especially hormone-dependent cancers. The purpose of our research was to explore the biologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Hongzhu, Sun, Yanling, Wu, Qian, Wu, Zhe, Hu, Meichun, Sun, Yuanpeng, Liu, Yusi, Ma, Zi, Liu, Shangqin, Xiao, Wuhan, Liu, Fuxing, Ning, Zhifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031343/ https://www.ncbi.nlm.nih.gov/pubmed/32117782 http://dx.doi.org/10.3389/fonc.2019.01423

Ejemplares similares

PELP1 Suppression Inhibits Colorectal Cancer through c-Src Downregulation
por: Ning, Zhifeng, et al.
Publicado: (2014)

Expression of estrogen receptors, PELP1, and SRC in human spermatozoa and their associations with semen quality
por: Skibińska, Izabela, et al.
Publicado: (2022)

Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation
por: Englert-Golon, Monika, et al.
Publicado: (2021)

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
por: Truong, Thu H., et al.
Publicado: (2021)

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
por: Wei, Yaolu, et al.
Publicado: (2022)

Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling
por: Long, Lingli, et al.
Publicado: (2019)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer
por: Zhu, Jianlin, et al.
Publicado: (2022)

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
por: Altwegg, Kristin A., et al.
Publicado: (2023)

Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
por: Roy, Sudipa Saha, et al.
Publicado: (2013)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR
por: Vadlamudi, Ratna K., et al.
Publicado: (2007)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

The DR1-CSE/H(2)S system inhibits renal fibrosis by downregulating the ERK1/2 signaling pathway in diabetic mice
por: Li, Hongzhu, et al.
Publicado: (2022)

Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways
por: Li, Yang, et al.
Publicado: (2018)

Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC
por: Liu, Zexuan, et al.
Publicado: (2022)

Trihydrophobin 1 Phosphorylation by c-Src Regulates MAPK/ERK Signaling and Cell Migration
por: Wu, Weibin, et al.
Publicado: (2012)

Increased expression of PELP1 in human sperm is correlated with decreased semen quality
por: Skibinska, Izabela, et al.
Publicado: (2018)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold
por: Gordon, Jacob, et al.
Publicado: (2022)

PELP: Accounting for Missing Data in Neural Time Series by Periodic Estimation of Lost Packets
por: Dastin-van Rijn, Evan M., et al.
Publicado: (2022)

Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
por: Liu, Junhao, et al.
Publicado: (2021)

NOX4/Src regulates ANP secretion through activating ERK1/2 and Akt/GATA4 signaling in beating rat hypoxic atria
por: Wu, Cheng-zhe, et al.
Publicado: (2021)

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma
por: Wang, H, et al.
Publicado: (2014)

Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
por: Li, Yan, et al.
Publicado: (2017)

Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway
por: WU, XUE, et al.
Publicado: (2016)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC
por: Davis, Thomas B., et al.
Publicado: (2019)

Dasatinib inhibits primary melanoma cell proliferation through morphology-dependent disruption of Src-ERK signaling
por: WU, JIANGHONG, et al.
Publicado: (2013)

TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways
por: Wang, Yuhui, et al.
Publicado: (2017)

RSU-1 interaction with prohibitin-2 links cell–extracellular matrix detachment to downregulation of ERK signaling
por: Wang, Meiling, et al.
Publicado: (2020)

Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
por: Wang, Jing, et al.
Publicado: (2013)

Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death
por: Girard, Brian J., et al.
Publicado: (2015)

The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes
por: Wang, Xingen, et al.
Publicado: (2019)

Inflammation-induced PELP1 expression promotes tumorigenesis by activating GM-CSF paracrine secretion in the tumor microenvironment
por: Vuttaradhi, Veena Kumari, et al.
Publicado: (2021)

ERK5 promotes Src-induced podosome formation by limiting Rho activation
por: Schramp, Mark, et al.
Publicado: (2008)

Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells
por: Zeng, Juan, et al.
Publicado: (2018)

Overexpression of PELP1 in Lung Adenocarcinoma Promoted E(2) Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the Patients
por: Zhang, Dongmei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q0hpdptpfcgvdh05q2u9n5lrec